BRPI0923540A2 - "derivados de 3-(3-pirimidin-2-ilbenzil)-1,2,4-triazolo[4,3-b]piridazina" - Google Patents
"derivados de 3-(3-pirimidin-2-ilbenzil)-1,2,4-triazolo[4,3-b]piridazina"Info
- Publication number
- BRPI0923540A2 BRPI0923540A2 BRPI0923540A BRPI0923540A BRPI0923540A2 BR PI0923540 A2 BRPI0923540 A2 BR PI0923540A2 BR PI0923540 A BRPI0923540 A BR PI0923540A BR PI0923540 A BRPI0923540 A BR PI0923540A BR PI0923540 A2 BRPI0923540 A2 BR PI0923540A2
- Authority
- BR
- Brazil
- Prior art keywords
- ylbenzyl
- triazolo
- pyrimidin
- pyridazine derivatives
- pyridazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008062825A DE102008062825A1 (de) | 2008-12-23 | 2008-12-23 | 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo [4,3-b]pyridazin-derivate |
PCT/EP2009/008442 WO2010072301A1 (de) | 2008-12-23 | 2009-11-26 | 3-(3-pyrimidin-2-yl-benzyl)- [1,2,4] triazolo [4,3-b] pyridazin-derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0923540A2 true BRPI0923540A2 (pt) | 2016-01-26 |
Family
ID=41694747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0923540A BRPI0923540A2 (pt) | 2008-12-23 | 2009-11-26 | "derivados de 3-(3-pirimidin-2-ilbenzil)-1,2,4-triazolo[4,3-b]piridazina" |
Country Status (15)
Country | Link |
---|---|
US (1) | US8426397B2 (pt) |
EP (1) | EP2367827B1 (pt) |
JP (1) | JP5497783B2 (pt) |
KR (1) | KR20110098852A (pt) |
CN (1) | CN102264742B (pt) |
AR (1) | AR074687A1 (pt) |
AU (1) | AU2009331996B2 (pt) |
BR (1) | BRPI0923540A2 (pt) |
CA (1) | CA2747932C (pt) |
DE (1) | DE102008062825A1 (pt) |
EA (1) | EA201100967A1 (pt) |
ES (1) | ES2405269T3 (pt) |
MX (1) | MX2011006688A (pt) |
WO (1) | WO2010072301A1 (pt) |
ZA (1) | ZA201105439B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101869534B1 (ko) * | 2012-03-05 | 2018-06-20 | 한국화학연구원 | 신규한 트리아졸로 피리다진 유도체 및 그의 용도 |
AU2013289615B2 (en) * | 2012-07-10 | 2017-06-08 | Ares Trading S.A. | Pyrimidine pyrazolyl derivatives |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
IL125686A (en) | 1996-02-13 | 2002-11-10 | Zeneca Ltd | Quinazoline derivatives, processes for their preparation, pharmaceutical preparations containing them and their use in the manufacture of a drug with an anti-angiogenic effect and / or an effect of reducing vascular permeability |
WO1997032856A1 (en) | 1996-03-05 | 1997-09-12 | Zeneca Limited | 4-anilinoquinazoline derivatives |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
IL152682A0 (en) | 2000-05-31 | 2003-06-24 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
RU2003103603A (ru) | 2000-07-07 | 2004-08-20 | Энджиоджен Фармасьютикалз Лимитед (Gb) | Производные колхинола в качестве ингибиторов ангиогенеза |
WO2002004434A1 (en) | 2000-07-07 | 2002-01-17 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as vascular damaging agents |
WO2002083139A1 (en) | 2001-04-10 | 2002-10-24 | Merck & Co., Inc. | Inhibitors of akt activity |
US20090105234A1 (en) | 2005-08-03 | 2009-04-23 | John Colucci | EP4 Receptor Agonist, Compositions and Methods Thereof |
CA2630884A1 (en) * | 2005-11-30 | 2007-06-07 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-met and uses thereof |
RS55630B1 (sr) | 2005-12-21 | 2017-06-30 | Janssen Pharmaceutica Nv | Triazolopiridazini kao modulatori tirozin kinaze |
EP2032578A2 (en) | 2006-05-30 | 2009-03-11 | Pfizer Products Incorporated | Triazolopyridazine derivatives |
PE20080403A1 (es) | 2006-07-14 | 2008-04-25 | Amgen Inc | Derivados heterociclicos fusionados y metodos de uso |
AU2007309237B2 (en) | 2006-10-23 | 2012-03-22 | Sgx Pharmaceuticals, Inc. | Triazolo-pyridazine protein kinase modulators |
DE102008028905A1 (de) * | 2008-06-18 | 2009-12-24 | Merck Patent Gmbh | 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate |
-
2008
- 2008-12-23 DE DE102008062825A patent/DE102008062825A1/de not_active Withdrawn
-
2009
- 2009-11-26 MX MX2011006688A patent/MX2011006688A/es active IP Right Grant
- 2009-11-26 CN CN200980152037.3A patent/CN102264742B/zh not_active Expired - Fee Related
- 2009-11-26 BR BRPI0923540A patent/BRPI0923540A2/pt not_active IP Right Cessation
- 2009-11-26 CA CA2747932A patent/CA2747932C/en not_active Expired - Fee Related
- 2009-11-26 KR KR1020117017316A patent/KR20110098852A/ko not_active Application Discontinuation
- 2009-11-26 EP EP09756448A patent/EP2367827B1/de not_active Not-in-force
- 2009-11-26 WO PCT/EP2009/008442 patent/WO2010072301A1/de active Application Filing
- 2009-11-26 US US13/141,447 patent/US8426397B2/en active Active
- 2009-11-26 ES ES09756448T patent/ES2405269T3/es active Active
- 2009-11-26 AU AU2009331996A patent/AU2009331996B2/en not_active Ceased
- 2009-11-26 EA EA201100967A patent/EA201100967A1/ru unknown
- 2009-11-26 JP JP2011542690A patent/JP5497783B2/ja not_active Expired - Fee Related
- 2009-12-16 AR ARP090104910A patent/AR074687A1/es unknown
-
2011
- 2011-07-22 ZA ZA2011/05439A patent/ZA201105439B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2367827B1 (de) | 2013-02-27 |
EP2367827A1 (de) | 2011-09-28 |
EA201100967A1 (ru) | 2012-01-30 |
ES2405269T3 (es) | 2013-05-30 |
AU2009331996B2 (en) | 2015-10-22 |
CN102264742B (zh) | 2014-05-28 |
JP2012513419A (ja) | 2012-06-14 |
CN102264742A (zh) | 2011-11-30 |
JP5497783B2 (ja) | 2014-05-21 |
AR074687A1 (es) | 2011-02-02 |
US8426397B2 (en) | 2013-04-23 |
ZA201105439B (en) | 2012-03-28 |
DE102008062825A1 (de) | 2010-06-24 |
WO2010072301A1 (de) | 2010-07-01 |
MX2011006688A (es) | 2011-07-29 |
CA2747932A1 (en) | 2010-07-01 |
CA2747932C (en) | 2018-01-09 |
KR20110098852A (ko) | 2011-09-01 |
AU2009331996A1 (en) | 2011-08-11 |
US20110257173A1 (en) | 2011-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0919948A2 (pt) | Pirido[4,3-b]indois contendo porções rígidas | |
LTPA2018510I1 (lt) | Dioksa-biciklo[3.2.1]oktan-2,3,4-triolio dariniai | |
BRPI1014459A2 (pt) | derivados de 3-(1,2,3-triazol-4-il)pirrolo[2,3-b]-piridina" | |
BRPI0722088A2 (pt) | derivados de pirrolo[2,3-b]piridina como moduladores de cinase | |
DK2384326T3 (da) | Pyrrolo[2,3-d]pyrimidinforbindelser | |
ZA200906736B (en) | New 3-([1,2,4] Triazolo [4,3-A]Pyridin-7-YL) Benzamide derivatives | |
DK2229391T3 (da) | Pyrido[2,3-B]pyrazin-8-substituerede forbindelser og deres anvendelse | |
DOP2007000080A (es) | Piridin [3,4-b] pirazinonas | |
EG25765A (en) | Pyrido [2,3-B] pyrazine derivatives useful as herbicidal compounds | |
BR112012002110A2 (pt) | derivados de pirrolo[1,2-b]piridazina como inibidores de janus cinase | |
BRPI0822237A2 (pt) | Compostos de imidazo [1,2-a] piridina | |
BRPI0915417A2 (pt) | derivados de 3-(3-pirimidin-2-il-benzil)-[1,2,4]triazolo [4,3-b]piridazina como inibidores da met quinase | |
IL196106A0 (en) | Pyrro[1,2-b]pyridazinone compounds | |
BRPI0914301A2 (pt) | derivados de pirimidin-4-ona substituída | |
DE102008005493A8 (de) | 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate | |
ZA201107350B (en) | Imidazo [2 1 b] [1, 3, 4] thiadiazole derivatives | |
BRPI0819831A2 (pt) | derivados de amidas de áciodo 6,7-diidro-5h-imidazo[1,2-a]imidazol-3-carboxílico | |
PL2155712T3 (pl) | 3-(imidazolilo)-pirazolo[3,4-b]pirydyny | |
EP2142542A4 (en) | NEW IMIDAZO [4,5-B] PYRIDINE-7-CARBOXYLAMIDEAMIDE 704 | |
BRPI0914665A2 (pt) | derivados de pirimido[2,1-a]isoquinolin-4-ona substituída | |
BRPI0822239A2 (pt) | Composto de pirazolo[1,5-a] pirimidina | |
BR112012002801A2 (pt) | derivados de 3-heteroarilmetil-imidazo[1,2-b]piridazin-6-ila como moduladores de tirosina quinase c-met | |
BRPI0923085A2 (pt) | derivados de 3-(3-pirimidin-2-ilbenzil)-1,2,4-triazol[4,3-b]pirimidina | |
HK1142593A1 (en) | Pyrrole derivatives as p2y12 antagonists | |
BRPI0714317A2 (pt) | Utilização de derivados de imidazo [ 1,2-alfa] piridina -21- carboxamidas em terapêutica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |